Clinical Trial

A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Name: A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis — clinical trial record (NCT06672393)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated November 4, 2024 (before its estimated October 22, 2025 completion). Its status may not reflect the trial's current state.

Summary

This study has been designed to confirm the clinical efficacy and safety of HS-10374 in the treatment of moderate to severe plaque psoriasis.

Trial Details

NCT Number	NCT06672393
Lead Sponsor	Hansoh BioMedical R&D Company
Conditions	Psoriasis
Enrollment	375 participants
Start Date	2024-11-04
Primary Completion	2025-10-22 (estimated)
Study Completion	2026-06-29 (estimated)
Updated on ClinicalTrials.gov	2024-11-04